Landmark TB Trial Identifies Shorter-Course Treatment Regimen
Washington (ISJ): Results from an international, randomized, controlled clinical trial indicate that a four-month daily treatment regimen containing high-dose, or “optimized,” rifapentine with moxifloxacin is...